EcoR1 Capital
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Regenerative Medicine
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Infectious Diseases
- Immunology
- Genomics
- Rare Diseases
Investment Size:
50,000,000 to 150,000,000 USD
Investor Details Founded: 2012
EcoR1 Capital is a San Francisco-based investment firm specializing in biotechnology and pharmaceutical sectors. Established in 2012, the firm focuses on identifying and investing in innovative therapeutic solutions that can significantly improve patient outcomes. By partnering with bold entrepreneurs dedicated to advancing medical research, EcoR1 Capital aims to propel the discovery and development of life-saving breakthroughs.
The firm's investment approach is holistic, evaluating exceptional management teams, strong scientific foundations, and rational financing strategies. EcoR1 Capital's portfolio includes companies at various stages of development, from seed to late-stage investments, across a wide range of therapeutic areas. Their commitment to advancing medical research is evident in their diverse portfolio and active engagement in the biotech community.
Requirements
- Qualified purchasers for Venture Funds and SPVs
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- ReCode Therapeutics
- Attovia Therapeutics
- Scorpion Therapeutics
Mentioned In
-
$14.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of EcoR1 Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim